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Abstract: The complex molecular machines responsible for genome replication encounter many
obstacles during their progression along DNA. Tolerance of these obstructions is critical for efficient
and timely genome duplication. In recent years, primase-polymerase (PrimPol) has emerged as a
new player involved in maintaining eukaryotic replication fork progression. This versatile replicative
enzyme, a member of the archaeo-eukaryotic primase (AEP) superfamily, has the capacity to perform
a range of template-dependent and independent synthesis activities. Here, we discuss the emerging
roles of PrimPol as a leading strand repriming enzyme and describe the mechanisms responsible for
recruiting and regulating the enzyme during this process. This review provides an overview and
update of the current PrimPol literature, as well as highlighting unanswered questions and potential
future avenues of investigation.
Keywords: primase; polymerase; AEP; PrimPol; DNA replication; priming; translesion synthesis;
damage tolerance
1. Introduction
The eukaryotic replisome is a highly co-ordinated complex of molecular machines, tasked with
efficiently duplicating the genome whilst maintaining a near-perfect level of accuracy. At the heart of
the replisome lie the classical DNA polymerases (Pols) α, δ, and ε, which together perform the bulk
of the “reading” and copying during replication [1]. These enzymes are exceptionally specialised to
faithfully duplicate intact DNA but, consequently, are also highly sensitive to perturbations in the DNA
template, resulting in the slowing and stalling of replication forks in the presence of replication stress [2].
Many endogenous and exogenous sources contribute to replication stress. Unrepaired DNA
lesions generated by inherent metabolic processes within the cell, in addition to external chemical
and physical mutagens, serve as potent blocks to the progression of the canonical replicative DNA
Pols [3]. Furthermore, non-B DNA secondary structures and collisions between the replisome and
transcription machinery also lead to fork stalling and potentially collapse [4,5]. Aside from direct
blockages, repetitive DNA sequences, common fragile sites, ribonucleotides incorporated in the
template strand, and limiting pools of nucleotides, can all also act as sources of replication stress [6–8].
In order to maintain replication in the presence of stalled and damaged replication forks, eukaryotes
possess a number of distinct damage tolerance and fork restart mechanisms [9]. The deployment of
these mechanisms differs depending on which template strand is affected. Obstacles encountered on
the lagging strand are easily overcome due to the discontinuous nature of lagging strand replication,
where primers are repeatedly generated for Okazaki fragment synthesis. This allows resumption of
lagging strand synthesis downstream of a lesion, or obstacle, through use of a newly generated primer
to reinitiate replication, leaving behind a single-stranded DNA (ssDNA) gap [10,11].
The situation on the leading strand is more complex with numerous restart pathways available [9].
However, in the last decade evidence has emerged indicating that repriming downstream of lesions
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and secondary structures also occurs on the leading strand, suggesting that eukaryotic leading strand
replication is not exclusively continuous as first thought [11,12]. Indeed, repriming of leading strand
replication in prokaryotes is now well documented [13,14]. In addition to repriming, stalled replication
forks can also utilise translesion synthesis (TLS) to directly replicate over damaged nucleobases in
the template strand. Here, specialised, but error-prone, damage tolerant Pols, predominantly of the
Y-family, replace the replicative Pol and synthesise a short section of DNA over the lesion, before
handing back over to the replicase [15,16]. It is widely believed that TLS can occur both at the
replication fork and post-replicatively to fill in ssDNA gaps left opposite damaged bases as a result
of repriming [17–20]. Such gaps may also appear due to the firing of dormant replication origins
downstream of a stalled fork, a process which can itself rescue replication [21]. Aside from TLS, ssDNA
gaps left opposite lesions can also be filled in an error-free manner through recombination-mediated
template switching. Here, the newly synthesised undamaged sister chromatid is used as a template
for extension [22]. Template switching may additionally occur at the replication fork via fork reversal;
remodelling of the stalled fork generates a four-way junction through annealing of the two nascent
DNA strands, thus providing an undamaged template for continued extension [23].
DNA damage tolerance, in particular TLS, has long been associated with the specialised damage
tolerant Pols of the Y-family. However, more recently it is becoming clear that members of the
archaeo-eukaryotic primase (AEP) superfamily also display novel roles in DNA damage tolerance
and repair pathways [24]. In archaea, where many species lack Y-family TLS Pols, the replicative
primase is inherently TLS proficient [25]. This review will focus on a new player in eukaryotic
nuclear and mitochondrial DNA damage tolerance, and only the second human AEP to be identified,
primase-polymerase (PrimPol) (alternative names CCDC111, FLJ33167, EukPrim2 or PrimPol1), encoded
by the PRIMPOL gene on chromosome 4q35.1 [26–28]. After an overview and evolutionary history,
we will describe the domain architecture and biochemical features of the enzyme before moving on to
discuss recent advances in our understanding of its roles, recruitment and regulation in vertebrate cells.
2. Discovery and Evolutionary History of PrimPol
The AEP superfamily is evolutionarily and structurally distinct from the bacterial DnaG-type
primases which, like AEPs in archaea and eukarya, are absolutely required for DNA replication initiation
in bacteria [24]. Nevertheless, DnaG-like primases are also present in archaea, and likewise, AEPs have
been identified in bacteria [29]. In each case, these enzymes have diverged to fulfil alternative roles, for
example in bacteria a member of the AEP superfamily is employed, together with Ku and DNA ligase
homologues, in a non homologous end-joining (NHEJ) DNA break repair pathway [30,31]. It is likely
that the presence of AEPs in bacteria is a result of horizontal gene transfer (HGT), with the enzymes
originally being recruited for replication initiation by the archaeo-eukaryotic lineage following their
divergence from bacteria [24,32]. The catalytic core of AEPs is defined by two structural modules; an
N-terminal module with an (αβ)2 unit, and a C-terminal RNA recognition module-like (RRM-like) fold.
These two modules pack together, with the active site residues located in between them [32].
In 2005, detailed in silico analyses divided the AEP superfamily into 13 major families, which
were further organised into three higher order clades; the AEP proper clade, the nucleo-cytoplasmic
large DNA virus (NCLDV)-herpesvirus primase clade, and the primpol clade [32]. These analyses
also identified PrimPol and assigned it to the NCLDV-herpesvirus clade, whose members are only
present in eukaryotes and their viruses. This clade encompasses the iridovirus primase and herpes-pox
primase families, PrimPol belonging to the latter. Members of the herpes-pox primase family possess a
conserved C-terminal β-strand-rich region, which replaces the Primase C Terminal (PriCT) domain
of the iridovirus primase family [32]. The NCLDV-herpesvirus primase clade is suggested to have
originated from bacteriophage or bacterial proteins possessing a fused AEP and PriCT-2 domain.
Herpes viruses likely acquired their primase from the NCLDV class, before replacing the C-terminal
PriCT domain with the characteristic β-strand-rich region [32].
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PrimPol orthologues are conserved across vertebrates, plants, and primitive eukaryotes including
species of fungi, algae, and protists, such as apicomplexans and the slime mold Dictyostelium. However,
PrimPol is notably absent from prokaryotes and a number of fungi and animal species, including
Caenorhabditis elegans and Drosophila [26,27,32]. This interrupted distribution of PrimPol, coupled with
the diversity of AEPs observed in mobile elements such as viruses and plasmids [24], suggests that
PrimPol was originally obtained through HGT by an early eukaryote and then lost on multiple separate
occasions. Importantly, PrimPol is not closely related to the eukaryotic replicative DNA primase small
subunit (Prim1), a member of the AEP-proper clade, and is dispensable for DNA replication in higher
eukaryotes [26,32]. It has been speculated that PrimPol may have originated as a DNA repair enzyme
in NCLDVs, potentially required due to their large genome size and lack of access to cellular DNA
repair enzymes during replication [32]. Likewise, PrimPol may play a role in DNA replication initiation
in these viruses.
3. What Can PrimPol Do? The Domain Architecture and Catalytic Activities of PrimPol
Since the initial identification of PrimPol in 2005 [32], a number of groups have purified and
characterised the recombinant protein, permitting insight into the architectural and biochemical
properties of the enzyme [26–28]. These studies revealed PrimPol’s impressive range of nucleotidyl
transferase activities, suggesting a number of potential roles in vivo. In this section, we will describe these
activities and the domain architecture of the protein, which underpins its catalytic flexibility (Figure 1).Genes 2017, 8, 20  4 of 25 
 
 
Figure 1. Domain architecture and catalytic activities of primase-polymerase (PrimPol). The domain 
architecture of PrimPol is depicted in the top panel. A helix (purple) located at the N-terminus is 
connected to ModN by a flexible linker and contacts the DNA major groove. ModN (blue) and ModC 
(orange) comprise the archaeo-eukaryotic primase (AEP) domain and contain motifs Ia, Ib, I, II, and 
III, required for template binding and catalytic activity. The zinc finger (ZnF) (green) contains three 
conserved cysteines and a histidine which coordinate a zinc ion and are required for primase, but not 
polymerase, activity. The replication protein A (RPA) binding domain (RBD) (red) containing RPA 
binding motif-A (RBM-A) and RBM-B (grey) is located at the C-terminus. A 100 amino acid (aa) scale 
bar is shown to the right. The catalytic activities of PrimPol are displayed below.  
 
Figure 1. Domain architecture and catalytic activities of primase-polymerase (PrimPol). The domain
architecture of PrimPol is depicted in the top panel. A helix (purple) located at the N-terminus is
connected to ModN by a flexible linker and contacts the DNA major groove. ModN (blue) and
ModC (orange) comprise the archaeo-eukaryotic primase (AEP) domain and contain motifs Ia, Ib, I,
II, and III, required for template binding and catalytic activity. The zinc finger (ZnF) (green) contains
three conserved cysteines and a histidine which coordinate a zinc ion and are required for primase, but
not polymerase, activity. The replication protein A (RPA) binding domain (RBD) (red) containing RPA
binding motif-A (RBM-A) and RBM-B (grey) is located at the C-terminus. A 100 amino acid (aa) scale
bar is shown to the right. The catalytic activities of PrimPol are displayed below.
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3.1. Domain Architecture and Structure
Previously, an alignment of PrimPol homologues identified 14 conserved regions within the
protein, including three characteristic AEP catalytic motifs (motifs I, II, and III) towards the N-terminus,
forming the AEP domain [32]. Interestingly, motif I displays the variant DxE, rather than the typical
DxD motif possessed by most AEPs. Motif I and motif III (xD) together form the divalent metal ion
binding site and are essential for the catalytic activity of the enzyme. Motif II (SxH) was predicted to
form part of the nucleotide binding site, and is again required for all catalytic activity [26,27,33,34].
Recently, the crystal structure of a ternary complex of the AEP domain of PrimPol (residues 1–354)
bound to a DNA template-primer and incoming nucleotide was elucidated, confirming the existence
and role of these motifs and two additional motifs, Ia (RQ) and Ib (QRhY/F), which interact with the
template DNA strand [35]. The structure reveals that PrimPol’s catalytic core encloses the 3′-end of
the primer with two α/β modules, ModN and ModC, lining the cavity. ModN primarily interacts
with the template strand, whilst ModC contains the catalytic residues and interacts with the incoming
nucleotide, as well as the template strand. Intriguingly, the structure of PrimPol’s AEP domain does not
resemble a typical polymerase fold in any way. There is no thumb domain to hold the primer-template,
in fact the primer DNA strand almost completely lacks protein contacts, and ModC was shown to
function as both the finger and palm domains [35].
PrimPol also possesses a second conserved domain, a C-terminal UL52-like zinc finger (ZnF)
containing three conserved cysteines and a histidine, as is typical for herpes-pox primase family
members [32]. The first conserved cysteine and histidine residues of this domain coordinate a zinc ion
and are critical for the primase, but not polymerase, activity of the enzyme [34,36].
3.2. Primase Activity
As predicted by the initial in silico identification, PrimPol is an active primase that is able to utilise
both NTPs and dNTPs for primer synthesis, a unique ability amongst eukaryotic enzymes [26–28].
Surprisingly, PrimPol actually displays a preference for dNTPs over NTPs during primer synthesis,
a feature more typically associated with archaeal primases [26]. Similar to the requirement of templated
pyrimidines for dinucleotide synthesis by Prim1, PrimPol only generates primers on dT containing
templates [26,37]. This primase activity is dependent upon an intact ZnF domain, which is consistent
with previous studies on the herpes simplex virus type I (HSV1) helicase/primase complex. Here,
primase activity was lost when key residues in the UL52 zinc-binding domain were mutated [38,39].
Interestingly, the ZnF domain of PrimPol has been shown to bind single-stranded (ss) but not
double-stranded (ds) DNA, suggesting that this module may be important for stabilising PrimPol on
ssDNA templates to allow synthesis of the initial dinucleotide [34]. The ability of PrimPol to synthesise
DNA primers de novo gives it the potential to reprime and restart replication downstream of DNA
damage lesions and fork-stalling obstacles in vivo.
3.3. Polymerase and Lesion Bypass Activities
In addition to its DNA and RNA primase activity, PrimPol is also a template-dependent DNA
polymerase, with an ability to bypass a number of DNA damage lesions. Notably, PrimPol can bypass
both oxidative and ultraviolet (UV)-induced lesions, including 8-oxo-guanine (8oxoG), and pyrimidine
(6-4) pyrimidone photoproducts (6-4PPs) [26,27]. A recent study analysing the kinetics of 8oxoG bypass
by PrimPol found that the enzyme incorporates dC (error free) opposite the lesion with 6-fold higher
efficiency than dA (error prone). Incorporation of dC opposite 8oxoG occurred at ≈25% efficiency
compared to an unmodified templating dG, suggesting that PrimPol has the potential to function as
an efficient TLS Pol in vivo [40]. However, the accuracy of bypass differs in other reports, in some
instances being only 50% error-free [26,34,41,42]. In the case of 6-4PPs, PrimPol bypasses the lesion
in an error-prone manner [26]. Although unable to directly traverse a cyclobutane pyrimidine dimer
(CPD), PrimPol can extend from mismatched bases opposite a CPD [26]. Additionally, a truncated
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form of PrimPol, lacking the ZnF domain, can facilitate TLS past a CPD [34]. In contrast, in the
presence of manganese, PrimPol’s TLS activity is altered allowing the full-length enzyme to extend
past cyclobutane pyrimidine dimers (CPDs) and abasic sites (Ap sites), in addition to 6-4PPs and
8oxoG lesions [36]. However, the usage of either magnesium or manganese as the primary cofactor for
PrimPol in vivo remains unclear.
3.4. Lesion Skipping and Template Independent Extension
Despite displaying the ability to directly read through some damaged nucleobases, such as 8oxoG,
it appears that PrimPol’s bypass of more bulky or distorting lesions is facilitated through a pseudo-TLS
mechanism. Here, PrimPol is able to re-anneal the primer to a new position downstream of the
lesion prior to extension, thus looping out the templating lesion and generating a shorter extension
product than would be produced from strict template-dependent extension [27,36,43]. This activity
is enhanced in the presence of manganese, permitting bypass of 6-4PPs, CPDs, and Ap sites by
pseudo-TLS [27,36]. Intriguingly, this characteristic is reminiscent of the Ap site bypass strategy
employed by the primase/polymerisation domain (PolDom) of Mycobacterium tuberculosis DNA ligase
(LigD) [44,45]. The ability of manganese to stimulate primer-realignment and template scrunching
by PrimPol offers a clear explanation for the altered TLS ability of the enzyme in the presence of this
metal ion. It has also been reported that manganese increases both PrimPol’s polymerase activity and
affinity for DNA, compared to magnesium [40].
Notably however, manganese also promotes promiscuous template-independent extension
by PrimPol, resulting in the generation of non-complementary homopolymeric strands [34].
The mutagenic effect of manganese on polymerase activity, through increased reactivity and promotion
of non-template-directed nucleotidyl transfer, has been clear for several decades [46–50]. Moreover, the
bypass of lesions via template scrunching is potentially more detrimental than beneficial to genomic
integrity, due to the high risk of generating frame-shift mutations. Therefore, it seems likely that more
low-risk mechanisms would be employed in vivo where available.
The lower affinity of PrimPol for DNA and incoming nucleotides in the presence of magnesium
is often taken as support for manganese as the enzyme’s primary metal ion cofactor in vivo [40].
However, PrimPol’s inherent low affinity for DNA and dNTPs, when using magnesium as a cofactor,
may actually act as an important mechanism to regulate its activity. In support of this, it has previously
been shown that dNTP levels in yeast are increased 6–8-fold in the presence of DNA damage [51].
Importantly, TLS Pols often require ≈10 times greater dNTP concentrations for nucleotide binding
opposite a lesion, compared to a replicative Pol at an undamaged site [52,53]. Increased intracellular
dNTP concentrations have been found to correlate with an increase in damage tolerance, but also
increased mutation rates, potentially due to the unregulated participation of TLS Pols in ‘normal’
replication [51]. Thus, in yeast it appears that the in vivo activity of TLS Pols is partly regulated by
dNTP levels, which increase after DNA damage, consequently restricting the contribution of these Pols
to ‘normal’ DNA replication. Intriguingly, ribonucleotide reductase has been found to be up-regulated
in response to DNA damage in all studied organisms, suggesting that increased dNTP synthesis
in response to damage may be a conserved mechanism across all domains of life [54]. Similarly,
PrimPol’s relatively poor affinity for DNA may be overcome in vivo by association with other factors,
such as replication protein A (RPA) and polymerase-delta interacting protein 2 (PolDIP2 or PDIP38),
again acting to regulate the enzyme by only recruiting it to loci where it is actually required [28,41,55].
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Additionally, it is not clear whether the relatively low intracellular concentrations of manganese
(0.1 to 40 µM) [56–58], compared to magnesium (0.21 to 0.24 mM) [59,60], are sufficient to support
the manganese-dependent TLS activities of PrimPol in vivo. Indeed, PrimPol required manganese
concentrations of 200–1000 µM to facilitate pseudo-TLS bypass of an abasic site in vitro, whilst 100 µM
did not permit any observable bypass [43]. Thus, the cellular relevance of these activities is not
immediately clear. One intriguing possibility is that PrimPol utilises manganese in the mitochondria
only [40]. Here, dNTP concentrations are lower than those in the cytosol, there is a dearth of TLS
Pols, manganese uptake is increased in response to oxidative stress, and the high copy number nature
of mitochondrial DNA (mtDNA) may allow more promiscuous lesion bypass mechanisms to be
employed [40,61]. That said, more recent in vitro reconstitution experiments argue against a TLS-like
role for PrimPol in oxidative damage bypass during mitochondrial DNA replication [42].
3.5. Fidelity, Mutagenic Signature, and Processivity
Typically, the price paid by Pols for DNA damage tolerance is a significant decrease in both
fidelity and processivity. Whilst the structural features of replicative Pols confer extremely efficient
and high fidelity DNA synthesis, TLS Pols possess more spacious active sites, altered finger and thumb
domains, and lack proofreading exonuclease capabilities. These characteristics permit bypass of bulky
lesions, but result in greatly decreased fidelity and processivity on undamaged DNA templates [16].
Likewise, the eukaryotic replicative primase exhibits poor fidelity compared to replicative Pols [62–64].
Rather unsurprisingly, PrimPol, which combines both TLS and primase capabilities, exhibits high
error rates of ≈1 × 10−4, comparable with Y and X-family Pols [55]. Unlike these Pols however,
PrimPol generates insertion-deletion (indel) errors at a much higher frequency than substitution
mutations, which may be a result of its template scrunching ability [55]. Manganese acts to further
decrease PrimPol’s fidelity on undamaged DNA and even more so on 8oxoG containing templates [40].
In addition to poor fidelity, PrimPol shares the characteristic of low processivity with canonical TLS
Pols, incorporating only 1–4 nucleotides per binding event [34]. Intriguingly, the enzyme’s processivity
was found to be negatively regulated by its ZnF domain, which may act to stabilise DNA binding and
allow primer synthesis, whilst additionally limiting primer extension. Removal of the ZnF domain has
also been found to lower PrimPol’s fidelity, suggesting the domain acts to regulate processivity and
fidelity, as well as enabling primase activity [34].
4. What Does PrimPol Do? The Role of PrimPol in DNA Replication
The biochemical classification of PrimPol as both a RNA/DNA primase and a TLS Pol clearly
suggests a role in DNA replication and damage tolerance. Moreover, these two characteristics give
PrimPol the potential to assist the replisome in two different ways; through TLS or repriming. In this
section, we will describe the in vivo characterisation of the enzyme, as well as the consequences of its
deletion on the cell. Using this information, we will discuss recent advances in our understanding of
the cellular roles of PrimPol (Figure 2).
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sunlight and a predisposition to skin cancer [16]. This is thought to occur due to mutagenic bypass of 
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Figure 2. Repriming roles of PrimPol in nuclear DNA replication. PrimPol is able to reprime
and reinitiate leading strand replication downstream of a range of replicase stalling obstacles.
Here, the ability of PrimPol to reprime downstream of DNA lesions, G4 secondary structures, and
chain-termin ting nucleotide a alogues, is highlighted. Following repriming, replication can proceed
and the resul ing single-stra ded DNA (s DNA) gap is filled through translesion synthesis (TLS) or
template switching mechanisms, permitting subsequent repair or removal of the obstac e. Only the
CDC45, MCM, GINS (CMG) complex, Pol ε, PrimPol, and RPA, are shown for simplicity. A key for
identifying each factor is shown below. CTNA: chain-terminating nucleoside analogues.
4.1. PrimPol—A DNA Damage Tolerance Enzyme
DNA damage tolerance is critical to support continued replisome progression in the presence
of unrepaired DNA damage. An inability to tolerate this damage can lead to prolonged fork stalling,
collapse a d, ultimately, genome instability and/or cell death. The importance of DNA damage
tolerance in pr serving genomic integrity is highlighted by the conseque c s on human health of
dysfunction in these mechanisms. An obvious example is the variant form of xeroderma pigmentosum
(XPV). Here, mutation of Pol η, one of many Y-family TLS Pols, causes increased sensitivity to
sunlight and a predisposition to skin cancer [16]. This is thought to occur due to mutagenic bypass of
UV-induced CPDs by alternative TLS Pols.
Interestingly, loss of PrimPol in human XPV cells leads to a synergistic increase in UV sensitivity,
with the enzyme performing a distinct role from Pol η during this process [26]. In line with this,
PrimPol forms sub-nuclear foci, and is recruited to chromatin, in response to UV irradiati n [26,36].
Both hum n MRC5 and avian DT40 cells lacking PrimPol (PrimPol−/−) also accumulate an increased
number of stalled forks, or a r duced ability to restart stalled forks, following UV damage [26,28,36,41].
Unlike human cells, DT40 cells are hypersensitive to UV irradiation in the absence of PrimPol only,
potentially due to the faster doubling times and increased S-phase population of these cells [26].
Interestingly, it has recently been shown that PrimPol−/− avian cells are even more sensitive to UV
damage than previously appreciated [65]. In fact, these cells were found to be more sensitive than
those lacking Pol ηwhen analysed by colony formation assays. This effect was determined to be due to
an extended G2 arrest, which prevented cell cycle progression, rather than an increase in apoptosis [65].
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These reports clearly implicate PrimPol in the maintenance of replisome progression, or restart of
stalled replication forks, in the presence of UV damage lesions.
However, PrimPol is also involved in the tolerance of other types of DNA damage.
PrimPol−/− DT40 cells are hypersensitivity to methylmethane sulfonate (MMS), cisplatin, and
hydroxyurea (HU) [66]. Further deletion of Pols ζ and η in these cells leads to an additional increase in
damage sensitivity to a similar extent as in wild-type cells, again indicating an independent role for
PrimPol in DNA damage tolerance [66]. PrimPol is also required for recovery of stalled replication
forks following HU treatment in HeLa cells [28,36]. Notably, each of these DNA damaging agents acts
to stall the progression of replication forks. MMS causes the generation of abasic sites in the template
strand, cisplatin crosslinks DNA, and HU acts to inhibit ribonucleotide reductase and, consequently,
dNTP production. In contrast, loss of PrimPol does not sensitise cells to ICRF193, camptothecin, or
γ-rays, agents that produce DNA strand breaks. This is suggestive of a broad role for the enzyme
in damage tolerance, but not in break repair [66]. PrimPol associates with chromatin during G1
and S-phase and PrimPol−/− mouse embryonic fibroblasts (MEFs) present chromosome aberrations
indicative of S-phase defects, which are enhanced after aphidicolin treatment [26,36]. Collectively,
these findings place PrimPol at the replication fork during S-phase and indicate a role in the tolerance
of replicase-stalling DNA damage.
4.2. PrimPol Reprimes and Restarts Stalled Replication Forks
The DNA damage tolerance defects observed in the absence of PrimPol potentially indicates
that it acts as both a TLS polymerase and a repriming enzyme. However, more recent reports clearly
support the latter function [34,36,66–68]. Although PrimPol is described as a TLS Pol, the spectrum of
DNA damage types it can traverse by ‘true’ TLS is actually rather limited. Discounting pseudo-TLS
bypass, which may or may not be relevant in vivo, PrimPol is essentially only able to directly bypass
8oxoG lesions [26,27,34,36]. Moreover, a number of other Pols are also able to efficiently and accurately
bypass these lesions [69–71]. If PrimPol’s primary role were as a TLS Pol, this observation would be
at odds with the range of replicase-stalling DNA damaging agents it is involved in tolerating [66].
This implies that PrimPol most likely acts as a repriming enzyme for the tolerance of DNA damage
and this is supported by the study of separation of function mutants [34,36,66,67].
Mutation of PrimPol’s ZnF domain abolishes primase, but actually enhances polymerase
activity [34,36]. This important observation has permitted investigation into the requirement of primase
activity for the enzyme’s role during DNA replication in vivo. In each case, when PrimPol−/− cells
were complemented with the primase-deficient/polymerase-proficient ZnF mutant, it was unable to
rescue any of the observed damage tolerance defects [34,36,66]. In contrast, complementation with
a primase-proficient/reduced-polymerase mutant of PrimPol restored DNA damage tolerance to
wild-type levels [66,72]. In agreement with this, PrimPol was able to facilitate close-coupled repriming
downstream of lesions in vitro, which it cannot bypass by TLS [66]. Aside from increased sensitivity to
DNA damaging agents and decreased replication fork rates, PrimPol−/− and knockdown cells exhibit
persistent RPA foci and increased phosphorylation of Chk1 [28,36]. Both of these stress response
markers are indicative of the generation of stretches of ssDNA [11,73]. This would be an expected
consequence of a lack of repriming by PrimPol, resulting in the uncoupling of leading/lagging strand
replication and excessive strand-specific unwinding by MCM [11]. In agreement, cells compensate
for the loss of PrimPol by increasing both homologous recombination (HR) mediated fork rescue and
dormant origin firing [26,33,36]. These compensatory back-up mechanisms, in addition to redundancy
between PrimPol and TLS polymerases, may explain why PrimPol is dispensable for viability in
human cells and mouse models [27]. These observations give further credibility to a requirement for
PrimPol at the progressing replication fork during S-phase, which might not necessarily be the case if
a TLS-like role was being performed.
As previously mentioned, TLS can potentially occur both at the replication fork, as well as
post-replicatively, to fill in gaps left opposite lesions following repriming or dormant origin firing [16].
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Each of these possibilities are not mutually exclusive, but a number of studies point to post-replicative
gap-filling as the predominant role for TLS. In yeast, DNA damage tolerance mechanisms, including
TLS, have been found to operate effectively in a post-replicative manner, and ssDNA gaps, indicative
of repriming, accumulate following UV-damage [11,17,18]. Likewise, in human cells DNA replication
fork progression in the presence of UV damage was found to be independent of TLS and ssDNA
gaps opposite UV lesions were identified. It was concluded that these gaps were likely a result of
repriming downstream of lesions rather than dormant origin firing [12]. Importantly, mutation of Pol
η or other TLS factors does not appear to significantly alter replication fork rates in the presence of
damage [12,20]. This is in stark contrast to the effect of loss of PrimPol on replication fork progression
following damage, further supporting a repriming, rather than TLS, role for this enzyme in vivo.
4.3. PrimPol Bypasses Non-Canonical Replication Impediments
Whilst DNA damage lesions are some of the best characterised replication impediments, they are
not the only obstacles replication forks must overcome during their progression. In addition to the
B-form of dsDNA we have become familiar with since Watson and Crick’s famous model [74], genomic
DNA can also adopt a number of other secondary structures as a result of specific sequence motifs and
protein interactions [75]. One alternative DNA secondary structure, which has received increasing
attention as evidence for its formation in vivo grows, is the G-quadruplex (G4) [76]. G4s are produced
by the stacking of G-quartets, which form through alternative Hoogsten base-pairing between guanine
bases. These structures may potentially play an important role in transcription and DNA replication in
the cell, but they can also pose as major impediments to replisome progression [77–80]. Consequently,
cells possess a number of specialised helicases and Pols to replicate past G4s [81].
Previously, cells lacking fanconi anemia complementation group J (FANCJ) or REV1 DNA-directed
polymerase were found to stochastically lose Bu-1a protein expression [82,83]. Importantly, the BU-1A
locus contains a G4, which was determined to stall replication in these cells. This stalling causes
uncoupling of replication from histone recycling at the BU-1A locus and consequently leads to the
deletion of epigenetic marks, manifesting in loss of Bu-1a expression. It was recently identified using
Bu-1a read-out assays that PrimPol also plays a critical role in the bypass of these structures during
DNA replication [67]. Consistent with PrimPol’s behaviour at most DNA damage lesions, in vitro
analysis revealed that the enzyme is unable to directly read through G4s, but can bind to and facilitate
close-coupled repriming downstream of these structures. Vitally, close-coupled repriming ≈6 nt ahead
of the G4 would permit the appropriate recycling of histones, and thus maintain epigenetic marks and
Bu-1a expression. Bypass of G4 structures through repriming by PrimPol was confirmed in vivo using
the ZnF primase-deficient mutant discussed previously. Here, complementation of PrimPol−/− cells
with the ZnF mutant failed to prevent instability of Bu-1a expression, in contrast to the wild-type
protein, confirming that PrimPol’s primase activity is critical for G4 bypass [67]. Intriguingly, PrimPol
was found to only be required for G4 bypass during leading strand replication. Presumably, this is
because primers are constantly generated on the lagging strand due to the discontinuous nature of
DNA synthesis on this strand.
Further evidence supporting a general role for PrimPol in repriming replication downstream of
fork-stalling obstacles is provided by studies of chain-terminating nucleoside analogues (CTNAs) [66].
CTNAs cause replication to stall, when incorporated into the 3′-termini of growing DNA polymers,
by preventing further extension as they lack the 3′ hydroxyl required for phosphodiester bond
formation [84,85]. Loss of PrimPol has been shown to cause hypersensitivity to a wide range of
CTNAs [66]. Critically, the inability of Pols to extend from CTNAs rules out bypass by direct extension.
PrimPol was found to be important for the tolerance of CTNAs by repriming downstream. This role
was confirmed by both in vivo characterisation of the ZnF mutant and in vitro analysis of repriming
synthesis after CTNAs [66].
These critical findings not only establish that PrimPol deploys a repriming mechanism to bypass
G4s and CTNAs, in a similar manner to DNA damage lesions, they also point to the possibility that
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PrimPol is able to bypass a wide range of leading strand obstacles during normal and perturbed
replication. This is in contrast to canonical TLS Pols, which are typically highly specialised in the
lesions they can bypass. Consequently, it is likely PrimPol is broadly employed as a general mechanism
to reprime and restart replication ahead of many different leading strand replication impediments.
4.4. A Role for PrimPol in Mitochondrial DNA Replication?
The majority of genetic information in mammalian cells is stored in the nucleus. However, a
small proportion of DNA is also located in the mitochondria. Despite being only ≈16.6 kb long and
encoding just 13 polypeptides, mutation of the mitochondrial genome is responsible for a number of
mitochondriopathies and is implicated in various other pathologies including cancer, cardiovascular
diseases, and neurodegenerative disorders [86]. Unlike nuclear DNA, cells possess many copies of
mtDNA making it highly redundant. In line with this, the rate of mutagenesis is ≈10-fold greater in
the mitochondria than the nucleus [86]. A major function of mitochondria is the generation of ATP
through oxidative phosphorylation (OXPHOS). This process produces reactive oxygen species (ROS)
which can induce damage lesions, including 8oxoG and Ap sites, in mtDNA [86].
A significant proportion of PrimPol has been found to localise to the mitochondria where it
interacts with mitochondrial single-strand binding proteins (mtSSB), suggesting a potential role in
the tolerance of mtDNA damage [26,27,55,87]. This is supported by defects in mtDNA replication
and copy number observed in cells lacking PrimPol [27,87]. However, the ability to generate
viable PrimPol−/− mice demonstrates that this role is redundant. Indeed, mitochondrial RNA Pol
(POLRMT) is likely responsible for generating the initial primers essential for mtDNA replication [88].
These primers are then extended by Pol γ, which until recently was thought to be the only
mitochondrial DNA Pol [89]. In addition to PrimPol, more recent reports indicate that Pol θ and
Pol ζ are also involved in human mtDNA replication [90,91].
Given that few TLS Pols appear to localise to the mitochondria, in addition to the high levels of
ROS there, it was speculated that PrimPol may be involved in TLS bypass of mitochondrial 8oxoG
lesions and Ap sites [27]. In order to investigate this, a recent study analysed the ability of PrimPol to
assist the mitochondrial replisome in oxidative damage bypass by TLS [42]. Here, it was found that the
mitochondrial replisome is completely stalled by Ap sites and pauses significantly at 8oxoG lesions.
PrimPol did not enhance the bypass of either of these lesions, disagreeing with a TLS role in oxidative
damage bypass in the mitochondria [42]. Thus, it seems more likely that PrimPol functions to reprime
mtDNA replication downstream of blocking lesions, similar to its role in the nucleus. In addition
to oxidative damage, mtDNA is also subject to deletions. Intriguingly, these deletions map in close
proximity to G4-forming sequences [92]. In light of the role of PrimPol in repriming after G4s in nuclear
DNA replication, it would not be surprising if the enzyme fulfilled the same role in the mitochondria.
However, further work is required to confirm a repriming role for PrimPol here. The potential role for
PrimPol in the mitochondria has recently been reviewed in more detail [93].
4.5. Is PrimPol Involved in Somatic Hypermutation?
Generally, mutagenesis during DNA replication is avoided at all costs in order to preserve
genomic stability. However, an exception to this is during the development of the immune system.
Here, mutagenesis occurs in immunoglobulin (Ig) genes to enable variation in the generated antibodies.
This programmed mutagenesis is driven by activation-induced deaminase (AID), which deaminates
dC to dU [94]. Replication of dU facilitates C>T transitions. Additionally, dU may be further processed
by uracil DNA glycosylase (UNG) to generate Ap sites. TLS bypass of these Ap sites can alternatively
create C>A/G/T mutations due to the non-instructive nature of the lesion [95].
The involvement of TLS Pols in somatic hypermutation (SHM) at Ap sites led to speculation that,
if PrimPol functions as a TLS Pol in vivo, it might also modulate this mutagenesis. Analysis of
DT40 cells found that hypermutation and gene-conversion events are similar in wild-type and
PrimPol−/− cells [66]. Moreover, loss of PrimPol in wild-type and Pol η−/−/Pol ζ−/− avian cells did
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not significantly alter the mutation spectrum of the studied Ig gene. Intriguingly, another report, which
analysed large mutational data sets in mice, identified that PrimPol does have a subtle effect on SHM
outcome [68]. In this study, loss of PrimPol was found to selectively increase C>G transversions, but
did not affect other G/C or A/T mutations. Interestingly, PrimPol was found to specifically prevent
the generation of C>G transversions in the leading strand, potentially explaining the G>C over C>G
strand bias of somatically mutated IgH loci [68]. However, this anti-mutagenic activity of PrimPol
was attributed to the enzyme’s primase, rather than TLS polymerase, activity. It was concluded that
PrimPol preferentially reprimes downstream of Ap sites on the leading strand, therefore maintaining
fork progression and preventing error-prone TLS. The resulting ssDNA gap opposite the Ap site could
then be filled in by error-free homology directed repair. Fascinatingly, in the same report, studies of
invasive breast cancers suggested that this leading strand anti-mutagenic activity of PrimPol may be
genome wide.
Together, these reports establish that PrimPol does not act as a canonical TLS polymerase during
SHM. Rather, PrimPol affects the mutational outcome of SHM by repriming downstream of Ap sites
on the leading strand thus preventing C>G transversions. These findings, therefore, further support
mounting evidence that PrimPol’s primary role in DNA damage tolerance is to reprime leading strand
replication and not to perform TLS.
4.6. Why Doesn’t the Pol α-Primase Complex Reprime Leading Strand Replication?
The emerging role for PrimPol in repriming leading strand replication begs the question; why
doesn’t the replicative Pol α-primase complex fulfil this role? In E. coli, DnaG, the replicative primase,
efficiently reprimes replication ahead of replicase stalling DNA damage lesions, permitting bypass
of the damage without dissociation of the replisome [13,14]. Likewise in yeast which lack PrimPol,
leading strand repriming is presumably facilitated by Pol α-primase, suggesting that, at least in these
organisms, the replicative primase has the capacity to also fulfil this role.
Whilst the answer to this question is not completely clear, PrimPol does have one advantage
over Pol α-primase; it preferentially primes using dNTPs. This minimises the amount of RNA
processing required on the leading strand. Although ribonucleotides are routinely incorporated
during the initiation of each Okazaki fragment on the lagging strand and at replication origins
on the leading strand, their persistent presence in DNA can lead to genomic instability [96].
Ribonucleotides incorporated during primer synthesis are routinely removed through Okazaki
fragment maturation [97]. However, it is not clear how a DNA secondary structure or lesion requiring
bypass upstream of the primer would affect this process.
Ribonucleotides incorporated by replicative Pols are removed by ribonucleotide excision repair
(RER). Intriguingly, in RER deficient yeast leading strand ribonucleotides are removed through a
topoisomerase I (Top1) mediated mechanism, which likely also removes a subset of ribonucleotides
in RER proficient cells [97,98]. This mechanism of ribonucleotide removal, which does not appear to
occur on the lagging strand, is susceptible to causing genome instability. This makes ribonucleotides
present in the leading strand potentially more detrimental than those in the lagging strand. This is
supported by observations that loss of RER and increased ribonucleotide incorporation by Pol ε, but
not Pol α or Pol δ, is lethal [98].
Although RER deficient yeast are viable, loss of this pathway in mice results in embryonic
lethality [99]. Thus, the greater pressure on higher eukaryotes to minimise the presence of
ribonucleotides in their genomes may explain why PrimPol is employed for leading strand repriming
using dNTPs in these organisms. However, this enzyme has been lost in some lower eukaryotes as an
alternative repriming mechanism, possibly involving the replicative primase, appears to be available.
4.7. Why Is PrimPol Damage Tolerant In Vitro?
If PrimPol’s primary role in vivo is to reprime DNA replication, why does the enzyme display
TLS-like activity in vitro? Although it is possible that PrimPol’s TLS-like activity is important in the
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cell, recent studies suggest that the enzyme’s primase activity is more relevant for its in vivo role,
as discussed above. This opens up the possibility that this TLS activity is a ‘side effect’ of being a
primase and this is supported by a number of observations.
Recent studies of the RNA primase domains of human Pol α-primase provide insight into
the unique way primases interact with their DNA template and primer [100,101]. The RNA primase
associated with Pol α is a heterodimer composed of a small catalytic subunit, p49, and a large regulatory
subunit, p58. These reports identify that the C-terminal domain of p58 binds to the DNA/RNA junction
at the 5′-end of the RNA primer, whereas p49 binds and extends the 3′ end of the primer moving
away from p58. The p49 subunit makes few contacts with the DNA/RNA, resulting in distributive
activity. By only contacting the primer at the 5′ and 3′ ends, the primase is unable to sense modified
nucleotides in the RNA strand, potentially explaining the propensity of primases to perform TLS-like
extension [100,101]. The authors suggest that this binding mechanism is broadly applicable to most
primases. In the context of PrimPol, the ZnF is likely functionally equivalent of p58. Indeed, both
are flexibly tethered to the catalytic domain and required for template recognition during priming,
although PrimPol’s ZnF has only been shown to bind ssDNA [34,102]. Nevertheless, the ZnF domain
may bind the ssDNA immediately upstream of the 5′ end of the primer.
The crystal structure of PrimPol’s AEP domain potentially supports this model [35]. Here, only
the templating base is held in the active site cleft, with the rest of the 5′ template strand directed
out of the catalytic centre. Additionally, PrimPol lacks a thumb domain and makes few contacts
with the primer strand. This potentially prevents the enzyme from sensing damaged bases in the
template and allows them to be looped out. Furthermore, unlike TLS Pols, PrimPol does not possess
an ‘open’ active-site cleft and is unable to accommodate bulky lesions such as CPDs and 6-4PPs [35].
This provides further evidence that PrimPol is not a ‘true’ TLS Pol, rather it loops out bulky-lesions
during bypass, resulting in deletions.
The ability of primase-polymerases to perform TLS-like extension is well documented [24].
Some AEPs have co-opted this inherent catalytic versatility for use in other processes such as NHEJ,
becoming specialised and in some instances, losing their ability to prime [24]. However, PrimPol’s
primase activity is critical for its role in vivo and thus it is possible that the TLS-like activities observed
in vitro simply arise as a by-product of the structural features necessary for priming.
5. How Does PrimPol Get to Where It is Needed? The Recruitment of PrimPol to Stalled
Replication Forks
The studies described above strongly indicate that PrimPol’s main role in DNA replication is
to reprime ahead of impediments on the leading strand. In order to fulfil this role, PrimPol must be
efficiently recruited to ssDNA downstream of stalled replication forks. In this section, we will describe
recent advances in our understanding of the interactions and mechanisms governing recruitment
of PrimPol.
5.1. PrimPol Interacts with Single-Strand Binding Proteins
Replication fork stalling can cause uncoupling of leading and lagging strand synthesis,
consequently generating ssDNA stretches on either strand due to continued unwinding by the
replicative helicase [11]. The impact of this on the lagging stand is likely limited by the generation of
new Okazaki fragments. However, in the absence of leading strand fork restart, extended uncoupling
can produce stretches of ssDNA. In nuclear DNA replication, the resulting ssDNA is bound by RPA,
which in turn can trigger the S phase checkpoint response [103].
Unlike TLS Pols, PrimPol does not interact with proliferating cell nuclear antigen (PCNA) [55].
However, it does interact with both the major nuclear and mitochondrial single-strand binding
proteins (SSBs); RPA and mtSSB [28,55]. PrimPol’s interaction with RPA is mediated by its C-terminal
domain (CTD), which binds to the N-terminus of RPA70 (RPA70N), the largest subunit of the
RPA heterotrimer [55]. The structural basis for PrimPol’s interaction with RPA has recently been
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elucidated [104], identifying that PrimPol possesses two RPA binding motifs (RBMs) in its CTD
(RBM-A and RBM-B), which both bind to the basic cleft of RPA70N, independently of each other.
Interestingly, this cleft has previously been shown to interact with, and recruit, a number of different
DNA damage response proteins, including RAD9, MRE11, ATRIP, and p53 [105].
Together, these studies indicate that PrimPol may also be recruited to stalled replication forks
through its interaction with RPA; with mtSSB likely playing an analogous role in mitochondria.
5.2. RPA Recruits PrimPol to Stalled Replication Forks
Previously, it was identified that PrimPol’s CTD is required for its function and co-localisation
with RPA in vivo [28]. However, interpretation of these results is limited as removal of the whole
CTD has been shown to reduce primase activity in vitro and may also abrogate interactions with
other binding partners [34]. Structural studies of PrimPol-RPA complexes have enabled the in vivo
analysis of point mutants that disrupt this interaction. These studies identified that PrimPol’s RBM-A
is the primary mediator of the RPA interaction in vivo, whilst RBM-B appears to play a secondary role.
Furthermore, RBM-A mutants were unable to restore replication fork rates following UV-damage, in
comparison to the wild-type or RBM-B mutant protein [104]. These findings revealed that PrimPol’s
interaction with RPA is required for its cellular role. Moreover, this study also showed that this
interaction is responsible for the recruitment of PrimPol to chromatin, demonstrating that the enzyme
is recruited to stalled replication forks by RPA [104]. Intriguingly, mutations of key residues in each
RBM have been identified in cancer patient cell lines, adding further support that these motifs are
important for PrimPol’s function in vivo [104].
Aside, from identifying the mechanism by which PrimPol is recruited to stalled replication
forks; these studies also add to the growing evidence supporting a role for PrimPol as a repriming
enzyme. PrimPol’s recruitment to RPA, and lack of interaction with PCNA, suggests it binds to ssDNA
downstream of a stalled replicase on the leading strand, the ideal place to facilitate repriming following
initial leading/lagging strand uncoupling to prevent excessive ssDNA generation. A recent report
investigating the role of RAD51 recombinase (RAD51) in aiding replication across UV lesions supports
this [106]. Here, RAD51 and MRE11 depletion was found to favour ssDNA accumulation at replication
obstacles and subsequent PrimPol-dependent repriming. This also supports previous suggestions
that excessive unwinding of DNA following stalling of the replicase is sufficient to promote ssDNA
generation and repriming at replication impediments [12].
Further work is required to elucidate the exact mechanisms controlling PrimPol’s recruitment
by RPA to ssDNA. Interestingly, binding of MRE11 and RAD9 to RPA is enhanced upon RPA32C
phosphorylation [107,108]. Thus, phosphorylation of RPA may act to signal recruitment of DNA
damage response proteins, potentially including PrimPol [109].
6. Regulation of PrimPol during DNA Replication
Recent reports strongly indicate that PrimPol is recruited by RPA to the leading strand, following
replicase stalling, in order to reprime replication and prevent genome instability. However, PrimPol
is an error-prone enzyme and unscheduled or dysregulated activity could lead to mutagenesis [55].
In this section, we will discuss our current understanding of the mechanisms used to limit PrimPol’s
contribution to DNA synthesis during replication (Figure 3).
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Figure 3. Regulation of PrimPol by its ZnF domain and interacting partners. Top panel: PrimPol
is inherently self-re latory due to the restraining effect of its ZnF domain. The AEP and ZnF
domains of PrimPol form a hinge-like structure, connected by a flexible linker. Binding of PrimPol to
ssDNA is mediated by the ZnF domain, which binds 3′ relative to the AEP domain on the template
strand. Binding f t e ZnF stabilises the AEP domain, per itting primer synthesis. The AEP then
extends the i er, but i restricted by the maximum distance it can move away from the ZnF.
The enzyme subsequently dissociates leaving behind a short primer. This mechanism limits the
processivity of the PrimPol; Middle panel: PrimPol is regulated by single-strand binding proteins
(SSBs). At sub-saturating concentrations of RPA, the protein acts to recruit Pri Pol to the ssDNA
template, consequently stimulat g primer synthesis. In vivo, thi interaction is prim rily mediated
by PrimPol’s RBM-A, which binds to the basic cleft of RPA70N. At saturating RPA concentrations,
when the ssDNA template is fully coated, PrimPol cannot gain access and primer synthesis is inhibited.
This serves to limit where PrimPol can prime; Bottom panel: Polymerase-delta interacting protein 2
(PolDIP2 or PDIP38) enhances PrimPol’s primer extension activity by binding the AEP domain and
stabilising it on DNA.
6.1. Regulation of the Cellular Concentration of PrimPol
The simplest way to regulate the activity of a protein is by controlling its intracellular concentration.
This is especially true for proteins that are only required to act in response to a specific stress, for
example DNA damage response proteins. This strategy is utilised during the SOS response in E. coli.
Here, ≈40 DNA damage response genes are upregulated in response to DNA damage [110].
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In comparison to Prim1, PrimPol is expressed at very low levels in human U2OS cells (<500 protein
copies per cell compared to ≈13,300) [111]. This is, however, similar to the expression level of TLS Pols,
including η and κ. PrimPol mRNA expression peaks in G1-S phase, although the total protein levels
remain roughly constant throughout the cell cycle [36]. Thus, the increased association of PrimPol
with chromatin during the G1 and S phases of the cell cycle in unperturbed cells is a result of finer
mechanisms controlling recruitment to DNA, rather than increased expression. This may also be
the case with the increased recruitment of the enzyme to chromatin in response to DNA damage.
Nevertheless, the low level of PrimPol expression, in comparison to the replicative primase, acts as the
primary mechanism to restrict its contribution to ‘normal’ replication.
6.2. PrimPol Is Self-Regulating
The structural features afforded to PrimPol by virtue of being a primase also act as
inherent regulatory mechanisms. As mentioned previously, PrimPol displays very low processivity.
This distributive nature appears to be due to two key features. Firstly, the AEP catalytic domain has
a much smaller ‘footprint’ than most polymerases, potentially explaining why the enzyme binds so
poorly to DNA [35]. Secondly, the ZnF domain acts to negatively regulate PrimPol’s processivity
(Figure 3, top panel) [34].
It has been suggested that the p58 subunit of the replicative eukaryotic primase enforces a strict
counting mechanism on the enzyme [112]. Here, the p58 and p49 subunits form a hinge-like structure.
The enzyme binds to ssDNA in a ‘closed’ conformation, with p58 facilitating template recognition.
The p49 subunit then initiates primer synthesis, moving away from p58 that binds the 5′ end of the
primer [101,112]. Thus, an inherent counting mechanism is conferred by the maximum distance p49
can elongate the primer strand away from p58. The ZnF domain of PrimPol is thought to act in a similar
way [104]. In this scenario, the AEP domain and ZnF may form a hinge-like structure, connected by
a flexible linker. The enzyme probably binds to DNA in a closed conformation assisted by the ZnF
domain, which binds on the 3′ side relative to the AEP domain on the template strand. The AEP
domain can then synthesise and elongate the primer strand until further extension is restricted by
the ZnF domain (Figure 3, top panel). It is also conceivable that the AEP and ZnF domains bind
DNA in an open conformation, with the ZnF bound on the 5′ side relative to the AEP on the template
strand, extension would then be limited by inter-domain collisions. In the absence of the ZnF, PrimPol
displays increased, but still poor, processivity due to the weak affinity of the AEP domain for the DNA
template [34].
PrimPol is, therefore, self-regulating. The supervisory effect of the ZnF domain, which permits
priming but limits elongation, coupled with the AEP’s poor affinity for DNA, restricts the ability of
PrimPol to partake in significant unregulated DNA synthesis during DNA replication.
6.3. Regulation by Single-Strand Binding Proteins
The ability of primases to bind and prime on ssDNA gives them the potential to facilitate
unscheduled priming in vivo, wherever ssDNA is available. Despite limiting the synthesis of long DNA
tracts, PrimPol’s self-regulatory mechanisms do not restrict where it can prime. Dysregulated priming
is potentially highly detrimental to the cell, as these primers could be extended by other Pols.
To prevent this, PrimPol is also regulated by RPA and mtSSB (Figure 3, middle panel). Both of
these SSBs stimulate the activity of their respective replicative Pols, δ and γ [113,114]. In contrast,
both RPA and mtSSB severely restrict the polymerase activity of PrimPol [55]. Additionally, these
SSBs can also inhibit primase activity, as is the case with Pol α-primase [55,115]. More recently, it was
reported that RPA’s effect on PrimPol’s primase activity is highly concentration-dependent. In fact,
sub-saturating concentrations of RPA dramatically stimulate primer synthesis but inhibition occurs as
the concentration increases [104].
It is likely that both RPA and mtSSB act to prevent unscheduled priming events by blocking access
to the DNA template. Thus, PrimPol requires a free ssDNA interface adjacent to the SSB in order to be
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recruited (Figure 3, middle panel). This recruitment likely acts to enhance PrimPol’s poor affinity for
DNA, providing a platform for primer synthesis.
RPA binds ssDNA with a defined polarity [116–119]. Initially, the DNA-binding domain A
(DBD-A) and DBD-B oligonucleotide binding (OB) folds of RPA70 bind ssDNA in a tandem manner,
forming an 8-nt binding complex. The interface in contact with DNA is then extended to 20–30 nts by
the binding of DBD-C and DBD-D, which occurs in a defined 5′-3′ direction on the template strand [120].
This would likely position the RPA70N domain, which recruits PrimPol, 5′ relative to rest of the RPA
molecule on the template strand (Figure 3, middle panel). This suggests that PrimPol binds ahead of
RPA in vivo, with the ZnF contacting ssDNA adjacent to RPA and the AEP bound downstream.
The orientation of PrimPol’s interaction with RPA may explain the inhibition observed in primer
extension assays. By preferentially binding on the 5′ side of RPA, PrimPol would not be able to access
the primer stand at the 3′ end of the template. Additionally, replicative Pols are thought to be able to
easily displace RPA as they approach the protein from the 3′ side, encountering the weakly bound
DBD-D and DBD-C domains, before DBD-B and DBD-A [121]. This in turn shifts the equilibrium
from the 20–30-nt RPA complex, to the more weakly bound 8-nt mode, thus permitting displacement.
In contrast, if PrimPol binds to the 5′ side of RPA, it would move away from the protein, preventing
displacement in the same way. It is likely that this interaction also further enhances the regulation
of PrimPol’s processivity by ‘holding’ the ZnF domain and preventing continued extension by the
AEP domain.
6.4. What Generates the ssDNA Interface Required for PrimPol Recruitment?
The requirement of a ssDNA interface downstream of RPA for efficient PrimPol recruitment
begs the question: how is this free ssDNA interface generated in vivo? Although the answer to this
question is currently unknown, one obvious solution would be through the action of the replicative
helicase. Following stalling of the leading strand replicase, leading and lagging strand replication can
become uncoupled. Here, the replisome progresses in the absence of DNA synthesis on the leading
strand. Continued unwinding of duplex parental DNA by MCM generates ssDNA on the leading
strand, which is bound by RPA. Consequently, an RPA/ssDNA interface for PrimPol binding could be
generated directly behind the progressing MCM. Subsequent repriming by PrimPol would prevent
extended leading/lagging strand uncoupling, allowing leading strand replication to resume at the
progressing replisome. The short RPA-bound ssDNA gap left behind could then be filled by TLS or
template switching mechanisms.
In support of this, it has recently been shown that the mitochondrial replicative helicase, Twinkle,
can stimulate DNA synthesis by PrimPol, indicating that replicative helicases can potentially facilitate
PrimPol activity in vivo [42]. It is interesting to note that many DNA primases interact with replicative
helicases, with some even possessing their own helicase domains [112].
6.5. Regulation by PolDIP2
PolDIP2 was originally identified as a binding partner of the p50 subunit of Pol δ, in addition to
PCNA [122]. More recently, PolDIP2 was shown to interact with Pols η, ζ, λ, and Rev1 [70,123]. In vitro,
the protein stimulates the polymerase activity of Pol δ by increasing its affinity for PCNA, as well as
enhancing TLS by Pols η and λ [70]. These observations have led to suggestions that PolDIP2 may play
an important role in the switch between Pol δ and TLS polymerases during DNA replication [70,123].
PolDIP2 also significantly enhances the DNA binding and processivity of PrimPol’s AEP domain
(Figure 3, bottom panel) [41]. Additionally, PolDIP2 appears to be important for PrimPol’s function
in vivo, suggesting it may act as a way to positively regulate the enzyme’s activity. Notably, however,
this was not sufficient to relieve the negative effect of RPA or mtSSB on PrimPol’s polymerase activity.
It seems likely that PolDIP2 acts to assist PrimPol’s AEP domain during primer extension after synthesis
of the initial di-nucleotide, without necessarily allowing synthesis of long DNA tracts. Interestingly,
PolDIP2 binds to PrimPol at a region in close proximity to motifs Ia and Ib, identified in the recent
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crystal structure of PrimPol [35,41]. These motifs harbour the majority of the residues responsible
for mediating binding of the AEP domain to the DNA template. PolDIP2, therefore, potentially
changes the conformation of this region to enhance PrimPol’s affinity for the DNA template, resulting
in increased DNA binding and processivity. Additionally, PolDIP2 may also serve as a hand-off
mechanism to the replicative Pol, following primer synthesis by PrimPol (Figure 4).
Intriguingly, Pol δ has recently been implicated in extension of a small fraction of primers
synthesised by Pol α-primase on the leading strand during DNA replication in yeast [124]. Given that
yeast lack PrimPol, this small fraction of primers could in theory be products of repriming by Pol
α-primase. This raises the fascinating possibility that Pol δ can serve to extend primers on the
leading strand following a repriming event, before subsequent replacement by Pol ε. This could
possibly be due to the stalling of Pol ε at the initial impediment, or alteration of the core replisome
following leading/lagging strand uncoupling. In higher eukaryotes, these leading strand repriming
events appear to be facilitated by PrimPol, not Pol α-primase. Thus, PolDIP2 may act as a hand-off
mechanism from PrimPol to Pol δ, given the interaction with both proteins and ability of PolDIP2 to
enhance the Pol δ/PCNA interaction. However, more work is required to investigate this possible
mechanism (Figure 4).
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Figure 4. Role, recruitment, and regulation of PrimPol during DNA replication. Top panel: Pol ε is
stalled on the leading strand by a lesion, secondary structure, or CTNA. Lagging strand replication
continues, subsequently generating ssDNA on the leading strand. This ssDNA is bound by RPA as
the CMG complex progresses; Middle panel: The generation of an RPA / ssDNA interface provides
a platform for PrimPol recruitment. PrimPol requires a free ssDNA region adjacent to RPA and
thus is recruited to the exposed ssDNA behind the CMG complex. This recruitment is facilitated
by the interaction between PrimPol’s RBMs and RPA70N. Following recruitment, PrimPol reprimes
the leading strand; Bottom panel: PrimPol elongates its primer, assisted by PolDIP2, before further
extension is restricted by its ZnF and RPA interaction. The primer is then handed-off to the replicative
polymerase, possibly Pol δ, mediated by each protein’s interaction with PolDIP2.
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7. Conclusions and Perspectives
Nearly half a century ago, Rupp and Howard-Flanders identified the presence of ssDNA
gaps left opposite UV photoproducts following DNA replication in nucleotide excision repair
deficient E. coli [125]. A model was proposed which envisaged re-initiation of replication downstream
of the damage on both leading and lagging strand templates; the first suggestion of repriming.
The idea of leading strand re-initiation remained controversial until almost four decades later when
origin-independent leading strand re-initiation was observed [126]. Follow-up studies confirmed
that the replicative primase, DnaG, could reprime leading strand replication downstream of a lesion,
whilst the replisome remained associated with the template [13,14]. Over recent years, evidence
has accumulated to support leading strand repriming as a conserved mechanism for dealing with
replisome-stalling impediments in eukaryotes [11,12,18] and recent studies have established that
PrimPol’s major role in eukaryotic organisms is to act as a primase that facilitates the bypass of a wide
range of leading strand obstacles (Figure 4) [34,36,66–68,104,106].
Since the initial reports describing PrimPol only three years ago, studies from a number of
laboratories have greatly increased our understanding of the role, recruitment, and regulation of the
enzyme during DNA replication [26–28]. However, we are only just beginning to appreciate the novel
roles that PrimPol plays in DNA replication and damage tolerance. The exact interplay between
leading strand repriming by PrimPol and other DNA damage tolerance mechanisms, such as TLS,
is still not yet clear. It is possible that DNA damage tolerance mechanisms work to complement
repriming by filling in the resulting ssDNA gaps. Alternatively, repriming could occur when TLS at
the replication fork fails, in order to prevent extended leading/lagging strand replication uncoupling.
The redundancy between Pol α-primase and PrimPol in vivo is also an interesting avenue for future
studies. The reason for the apparent requirement of PrimPol for leading strand repriming in higher
eukaryotes, but not other organisms, is not yet completely clear. Although leading strand repriming
is emerging as the primary role for PrimPol during DNA replication, the catalytic versatility of the
enzyme may lend itself to disparate roles in other processes, such as transcription [43].
We now know that RPA serves to recruit PrimPol to stalled replication forks in the nucleus [104].
However, mtSSB has not yet been shown to play an analogous role in the mitochondria, although
an interaction between these proteins in vivo has been reported [55]. Additionally, it is possible that
post-translational modifications, as well as interactions with the replicative helicases, play a role in
this process [42]. The necessity of appropriate recruitment and regulation of PrimPol in the cell is
highlighted by the mutations of PrimPol’s RBMs identified in cancer patient cell lines, which likely
adversely affect recruitment of the enzyme [104]. The regulation of PrimPol appears to walk a fine line
between preventing and causing genetic instability, as PrimPol is inherently error-prone and also been
found to be over-expressed in some cancers, such as glioma [55,127]. Although we have highlighted
some of the known mechanisms regulating PrimPol’s activity here, it is likely that additional layers of
regulation remain to be discovered.
The hypersensitivity to DNA damaging agents observed in absence of PrimPol legitimises the
enzyme as a potential target for inhibition in combination with other DNA damage tolerance factors
and DNA damaging chemotherapeutics [26,36,66]. Similarly, PrimPol homologues in trypanosomes
have been identified as essential for survival and thus PrimPol-like proteins in other species may also
be potential targets for anti-parasitic drugs [33]. Further studies will be important in determining the
viability and usefulness of manipulating PrimPol in treating cancer and other diseases.
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